Apollo Capital Calls Out MediPharm Chairman Chris Taves (Managing Director, BMO Capital Markets) for Failure to Properly Communicate to Shareholders Details of David Pidduck's Past as CEO and VP of Marketing for OxyContin® Manufacturer Purdue Pharma

Stock Information for MediPharm Labs Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MediPharm Labs Corp.

MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
Apollo Capital Wins Proxy Contest at MediPharm Labs
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
Apollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World's Leading International Medical Cannabis Company
MediPharm Labs' Founder-CEO Pat McCutcheon Throws his Support behind Apollo Capital as Dissident

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.